NCT06344429View on ClinicalTrials.gov

Stellest Lenses and Low-concentration Atropine Myopia Control Among Children

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 20, 2023

Primary Completion Date

August 20, 2024

Study Completion Date

August 20, 2025

Conditions
Myopia
Interventions
DEVICE

Stellest Lenses

"All subjects are recruited and randomized to 3 treatment groups at the baseline visit.~A Group：Stellest Lenses spectacle (ST)"

COMBINATION_PRODUCT

Stellest Lenses+0.05% atropine

"All subjects are recruited and randomized to 3 treatment groups at the baseline visit.~B Group：Combined Treatment"

DRUG

Single vision Lenses+0.05% atropine

"All subjects are recruited and randomized to 3 treatment groups at the baseline visit.~C Group：0.05% Atropine with single vision"

Trial Locations (1)

833401

RECRUITING

Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City

All Listed Sponsors
lead

Essilor-Polylite Taiwan Co., Ltd.

INDUSTRY